ライフサイエンスコーパス: artificial tear

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 acy and tolerability versus cyclosporine and artificial tears.

2 eal thickness obtained after instillation of artificial tears.

3 eal thickness obtained after instillation of artificial tears.

4 % diclofenac sodium; and group IV, control + artificial tears.

5 D below the mean value for eyes administered artificial tears.

6 ditional therapies such as preservative free artificial tears.

7 Immediately after instillation of artificial tears, all measured variables increased signi

8 It is presently treated with artificial tear and anti-inflammatory eye drops that are

9 In the artificial tear and loteprednol groups, although no sign

10 During a period of dry eye, artificial tears and punctal plugs are helpful in preven

11 ces in therapy include improved nonpreserved artificial tears and therapies targeted at decreasing oc

12 DED by a clinician, (2) the prescription of artificial tears, and/or (3) symptoms of dry eyes for at

13 Patients were using artificial tears as needed.

14 allergic reaction followed by application of artificial tears (ATs), 5 minutes of cold compress (CC),

15 Artificial tears combined with CC reduced hyperemia more

16 roximately 0.15 mM glucose concentrations in artificial tear fluid solution.

17 They then used artificial tears for 2 weeks prior to low-humidity expos

18 lol 0.5% eye drops, or Group 2, who received artificial tears for 6 months.

19 treatment groups: group I, 0.5% cidofovir + artificial tears; group II, 0.5% cidofovir + 0.5% ketoro

20 ed that four of the six animals administered artificial tears had damage involving 100% of the neural

21 C-25 and artificial tears had no effect.

22 Artificial tear instillation alone or CC combined with A

23 red to both eyes twice daily for 7 days, and artificial tears, ketorolac, and diclofenac four times d

24 riamcinolone acetonide (TA), and lipid-based artificial tears (LBAT)-were tested in cadaveric porcine

25 with DED were randomized to receive topical artificial tears, loteprednol etabonate 0.5%, or lotepre

26 Twice daily applications of either artificial tears (n = 6), 0.5% betaxolol (n = 5), or 0.5

27 therapies such as preserved and nonpreserved artificial tears, nutritional supplements, topical cyclo

28 ise in measuring the dynamic distribution of artificial tears on the ocular surface.

29 r corneal surgery and 3 days later, received artificial tears or CsA eye drops for 6 weeks.

30 The artificial tears or lubricants are the therapy most used

31 was lower than that in animals administered artificial tears (P = 0.003).

32 he peptide in one of four delivery vehicles: artificial tears, PBS, methylcellulose, and aquaphor cre

33 oing SLT were randomized to receive placebo (artificial tears), prednisolone acetate 1%, or ketorolac

34 ender, preoperative and postoperative use of artificial tears, preoperative and postoperative margina

35 each of the first 4 extinction sessions, an artificial tear solution or tetracaine hydrochloride was

36 contact lens care disinfecting solutions or artificial tear solutions containing polyquaternium-1.

37 ting of the cornea, by applying and removing artificial tears, temperature changes (35 degrees C-15 d

38 For animals administered artificial tears, the mean IOP of the experimental eyes

39 zed 1:1 to receive a bimatoprost insert plus artificial tears twice daily or a placebo insert plus ti

40 Parasol plugs required less frequent artificial tear use at 6 months (P = .024).

41 visual analogue scale [VAS]), and history of artificial tear use within 30 days of study entry.

42 ement in ocular-surface health, reduction in artificial tear use, and improved contact lens comfort i

43 in dry eye symptoms, ocular-surface status, artificial tear use, contact lens comfort, and tear brea

44 sing the dexamethasone (visit 4) compared to artificial tears (visit 3) (P = .01).

45 No supplemental artificial tears were allowed.

46 t C-25 (10 mug/mL), cyclosporine (0.05%), or artificial tears were topically administered to eyes of

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。